Sonata Software Limited will announce its un-audited financial results for the quarter ended June 30, 2026, on August 6, 2026. The disclosure marks the release of the company's first-quarter performance for FY27, with management set to provide an update on operational metrics and financial health during a subsequent earnings conference call scheduled for August 7, 2026.

The Board of Directors approved the date for the results announcement during its meeting held on Thursday, August 6, 2026. The intimation regarding the schedule for the analysts' and investors' call was issued in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was signed by Mangal Kulkarni, Company Secretary, Compliance Officer and Head Legal, and submitted to the National Stock Exchange of India Limited and BSE Limited on July 30, 2026.

Earnings Call Schedule

The earnings conference call is designed to allow investors and analysts to review the quarterly performance and ask questions regarding the company's strategic direction. The session will take place on Friday, August 7, 2026, from 4:00 p.m. to 5:00 p.m. IST. Participants can join via Zoom or through an audio-only dial-in option.

Participants connecting via Zoom can view the presentation and raise their hand to ask questions. For those opting for the audio-only connection, pre-registration is required via the provided portal. Upon registration, participants receive a passcode and dial-in number. During the call, users must press *9 to raise their hand or *6 to unmute and state their name and company before asking a question.

Business Overview

Sonata Software operates as an AI-first Modernization Engineering company, leveraging its proprietary Platformation™ framework. The company reported over $1.2 Billion in revenue and employs more than 6,400 AI Engineers. Its services span Cloud, Data, AI, Dynamics, Test Automation, and Managed Services, supported by the Harmoni.AI Enterprise Platform. This platform includes Agent Bridge for governance, Agent Builder for development, and the Agent Marketplace for modular agents.

Headquartered in Bengaluru, Sonata Software maintains a global presence across the US, UK, India, Malaysia, Mexico, Australia, Germany, Switzerland, and Finland. The company serves Fortune 500 clients in Banking, Financial Services and Insurance; Healthcare and Lifesciences; Telecom, Media, and Technology; and Retail, Manufacturing and Distribution. It holds AWS Premier Tier Status and collaborates with partners including Microsoft, AWS, Salesforce, and Snowflake.

SONATA has launched a doctor-led preventive healthcare membership in New York, San Francisco, and Los Angeles. The service integrates deep biological testing, board-certified physicians, and clinical AI to create personalized care plans aimed at identifying health risks before disease onset. The founding membership is priced at $2,500 annually.

The membership model addresses the gap between abundant health data and the lack of clinical guidance to interpret it. SONATA performs deep clinical testing not typically included in routine primary care, such as whole-genome sequencing and DNA methylation analysis, and combines these results with a member's medical history and wearable data.

Membership Features

SONATA's offering includes a range of diagnostic and monitoring services designed to provide a comprehensive view of a member's health. The care model is continuous rather than a one-time test, with plans that evolve as a member's biology and goals change.

Technology and Care Model

SONATA utilizes clinical AI developed in-house to synthesize complex information across genomics, biomarkers, medical history, and ongoing care trends. While the AI assists in data processing, all clinical decisions, including interpretation, diagnosis, and prescribing, remain physician-led.

"Modern medicine is built on population averages, but no individual is the average," said David Deng, co-founder and CTO of SONATA. "SONATA's clinical AI synthesizes each member's genomics, epigenetics, biomarkers, and health records against clinical guidelines and the latest peer-reviewed research, so physicians can focus their time on listening to patients and building truly personalized care plans."

The company was co-founded by Sagan Schultz, MD, MBA, and David Deng. Schultz is a former McKinsey healthcare consultant and the first product manager at Linear, while Deng was a first-10 engineer at Ramp and a former member of the clinical genomics team at Flatiron Health. SONATA is backed by Lux Capital, Box Group, and Sunflower Capital.